Article Information
History
- January 17, 2024.
Article Versions
- Version 1 (April 14, 2022 - 12:30).
- Version 2 (April 22, 2022 - 09:49).
- Version 3 (August 31, 2023 - 12:01).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Joanna C. Porter1,2,
- Jamie Inshaw3,
- Vincente Joel Solis2,
- Emma Denneny1,2,
- Rebecca Evans2,
- Mia I. Temkin4,*,
- Nathalia De Vasconcelos4,*,
- Iker Valle Aramburu4,*,
- Dennis Hoving4,*,
- Donna Basire1,
- Tracey Crissell2,
- Jesusa Guinto2,
- Alison Webb2,
- Hanif Esmail2,5,
- Victoria Johnston2,5,
- Anna Last2,6,
- Thomas Rampling2,5,
- Elisa Theresa Helbig7,
- Lena Lippert7,
- Florian Kurth7,
- Bryan Williams2,5,
- Aiden Flynn3,
- Pauline T Lukey8,
- Veronique Birault9 and
- Venizelos Papayannopoulos4,*
- 1UCL Respiratory, University College London, UK
- 2University College London Hospitals NHS Trust, London, UK
- 3Exploristics, Belfast, N. Ireland
- 4Antimicrobial Defence lab, The Francis Crick Institute, London, UK
- 5National Institute for Health Research, University College London Hospital Biomedical Research Centre, UK
- 6Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK
- 7Charité – Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany
- 8Target to Treatment Consulting Ltd, Stevenage, UK
- 9Translation, The Francis Crick Institute, London, UK
- ↵*Correspondence:
Professor Joanna C Porter, joanna.porter{at}ucl.ac.uk and Venizelos Papayannopoulos, veni.p{at}crick.ac.uk
↵* contributed equally